Russell Investments Group
DNA icon

Russell Investments Group’s Ginkgo Bioworks DNA Stock Holding History

Russell Investments Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Buy
37,699
+14,604
+63% +$122K ﹤0.01% 2914
2026
Q1 		$142K Buy
23,095
+688
+3% +$5.72K ﹤0.01% 2969
2025
Q4 		$186K Buy
22,407
+992
+5% +$10.7K ﹤0.01% 2865
2025
Q3 		$312K Buy
+21,415
New +$256K ﹤0.01% 2645
2024
Q4 		– Sell
-7,800
Closed -$63.6K – 3719
2024
Q3 		$63.6K Buy
7,800
+5,742
+279% +$57.5K ﹤0.01% 2743
2024
Q2 		$27.5K Buy
2,058
+1,259
+158% +$37.6K ﹤0.01% 2886
2024
Q1 		$37.1K Buy
799
+791
+9,888% +$40.9K ﹤0.01% 2703
2023
Q4 		$566 Buy
8
+4
+100% +$245 ﹤0.01% 3113
2023
Q3 		$315 Sell
4
-10,373
-100% -$829K ﹤0.01% 3443
2023
Q2 		$772K Sell
10,377
-16,341
-61% -$967K ﹤0.01% 2059
2023
Q1 		$1.42M Buy
26,718
+25,952
+3,388% +$1.64M ﹤0.01% 1777
2022
Q4 		$51.8K Hold
766
– – ﹤0.01% 2734
2022
Q3 		$95K Buy
766
+269
+54% +$32.1K ﹤0.01% 2673
2022
Q2 		$47K Buy
+497
New +$60.6K ﹤0.01% 2738

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Russell Investments Group's DNA Position: Q2 2026 in Review

Russell Investments Group increased its Ginkgo Bioworks (DNA) stake by 63% in Q2 2026, buying an estimated $122K and bringing the position to 37,699 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2914.

Russell Investments Group first reported a position in DNA in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.42M in Q1 2023. 73 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Russell Investments Group held 37,699 shares of Ginkgo Bioworks worth $374K as of Q2 2026.
  • Russell Investments Group bought 14,604 Ginkgo Bioworks shares in Q2 2026, an estimated $122K.
  • Ginkgo Bioworks made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2914 holding.
  • Russell Investments Group first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 14 quarters since.
  • Russell Investments Group's Ginkgo Bioworks position peaked at $1.42M in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.